Skip to main content

Table 2 Clinical information and patient characteristics from the eligible studies

From: Efficacy and safety of apatinib in the treatment of osteosarcoma: a single-arm meta-analysis among Chinese patients

  1. Tian,2019: The study was divided into two groups based on the dose of apatinib, with group 1 as the high-dose group and group 2 as the low-dose group
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us